| HOME >> BIOLOGY >> TECHNOLOGY |
Loss from operations (3,896,315) (4,872,190)
Other income 290,880 569,769
Net loss available to common
stockholders $(3,605,435) $(4,302,421)
Basic and diluted loss per share $(0.25) $(0.35)
Weighted average shares outstanding:
Basic and diluted 14,149,963 12,298,424
ATRICURE, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
March 31, December 31,
2008 2007
Assets
Current assets:
Cash and cash equivalents $13,014,579 $13,000,652
Short-term investments 1,903,904 7,006,041
Accounts receivable, net 8,552,666 7,189,512
Inventories, net 6,305,013 5,266,155
Other current assets 1,418,648 1,400,163
Total current assets 31,194,810 33,862,523
Property and equipment, net 4,764,364 4,466,060
Intangible assets 780,278 850,653
Goodwill 6,763,259 6,763,259
Other assets 117,270 129,001
Total Assets $43,619,981 $46,071,496
Liabilities and stockholders' equity
Current liabilities:
Accounts payable and accrued
liabilities $9,220,499 $8,413,656
Current maturities of debt,
'/>"/>
| SOURCE AtriCure, Inc. Copyright©2008 PR Newswire. All rights reserved |